Ken Griffin Harmony Biosciences Holdings, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,200 shares of HRMY stock, worth $85,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,200
Previous 7,900
72.15%
Holding current value
$85,778
Previous $265,000
75.09%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding HRMY
# of Institutions
228Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$437 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$228 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$137 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$102 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$97.8 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...